Cargando…

650 Relative Vaccine Effectiveness of Live-Attenuated Versus Inactivated Influenza Vaccines in Children and Adolescents Aged 2–18 Years in Two Seasons – US Flu VE Network

Detalles Bibliográficos
Autores principales:	Clippard, Jessie, Thaker, Swathi, Monto, Arnold, Ohmit, Suzanne E., Zimmerman, Richard K., Nowalk, Mary Patricia, Gaglani, Manjusha, Jackson, Michael, Jackson, Lisa A., Belongia, Edward, Mclean, Huong, Spencer, Sarah, Fry, A, Flannery, Brendan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781846/ http://dx.doi.org/10.1093/ofid/ofu051.95

Ejemplares similares

535 Effectiveness of Seasonal Influenza Vaccines against Influenza A(H1N1)pdm09 Illness during Three Influenza Seasons, US Flu VE Network
por: Flannery, Brendan, et al.
Publicado: (2014)

2760. Accounting for Vaccination History in Estimates of Current Season Vaccine Effectiveness in the US Flu VE Network, 2012–2013 Through 2017–2018
por: Kim, Sara S, et al.
Publicado: (2019)

Interim Estimates of 2013–14 Seasonal Influenza Vaccine Effectiveness — United States, February 2014
por: Flannery, Brendan, et al.
Publicado: (2014)

988. Effectiveness of Seasonal Influenza Vaccines Against Influenza A(H3N2) Illness Among Children Aged <18 Years, US Flu VE Network, 2010–2018
por: Flannery, Brendan L, et al.
Publicado: (2018)

Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2015
por: Flannery, Brendan, et al.
Publicado: (2015)

900. Effect of Influenza Vaccine Priming on Current Season Vaccine Effectiveness among Children and Adolescents, US Flu VE Network 2014–2015 Through 2017–2018
por: Chung, Jessie R, et al.
Publicado: (2019)

1055 Antibody Response to Intradermal and High Dose Influenza Vaccine in 2012-13 Among Adults Who Did and Did Not Respond to Standard Dose Vaccine in 2011-12
por: Sundaram, Maria, et al.
Publicado: (2014)

Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season
por: Flannery, Brendan, et al.
Publicado: (2017)

2062. Improving Antibiotic Prescribing in the Ambulatory Care Setting—Stewardship through Influenza Vaccination, US Flu VE Network 2013–2014 Through 2017–2018
por: Smith, Emily, et al.
Publicado: (2019)

1057 Factors Associated with Influenza A (H1N1)pdm09 (pH1N1) Vaccine Failure among Children Aged 5-17 Years
por: Mclean, Huong, et al.
Publicado: (2014)

Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type
por: McLean, Huong Q., et al.
Publicado: (2015)

Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017
por: Flannery, Brendan, et al.
Publicado: (2017)

533 Persistence of Antibody to Influenza Hemagglutinin over Two Influenza Seasons
por: Petrie, Joshua G., et al.
Publicado: (2014)

2734. Lack of Influence of Early Exposure to Influenza A(H3N2) Viruses on Vaccine Effectiveness Against A(H3N2)-Associated Illness in US Children <18 Years, 2016–2018
por: Ladva, Chandresh N, et al.
Publicado: (2019)

1056 Factors Associated with Pre-season Seroprotection to B Lineage Influenza Viruses in Children
por: King, Jennifer, et al.
Publicado: (2014)

Hospitalization following outpatient medical care for influenza: US influenza vaccine effectiveness network, 2011‐12—2015‐16
por: Appiah, Grace D., et al.
Publicado: (2018)

Influenza Vaccine Effectiveness among Elderly and Non-Elderly Adults Aged ≥45 Years in the United States, 2011–2012 to 2015–2016
por: Havers, Fiona P, et al.
Publicado: (2017)

Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017
por: Gaglani, Manjusha, et al.
Publicado: (2020)

Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018
por: Flannery, Brendan, et al.
Publicado: (2018)

Prior SARS‐CoV‐2 infection and COVID‐19 vaccine effectiveness against outpatient illness during widespread circulation of SARS‐CoV‐2 Omicron variant, US Flu VE network
por: Tartof, Sara Y., et al.
Publicado: (2023)

Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011‐2016
por: Balasubramani, Goundappa K., et al.
Publicado: (2020)

1339 Measles and Mumps Antibody Response in Young Adults after a Third Dose of Measles-Mumps-Rubella Vaccine
por: Fiebelkorn, Amy Parker, et al.
Publicado: (2014)

Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons
por: Havers, Fiona P., et al.
Publicado: (2018)

Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness — United States, February 2019
por: Doyle, Joshua D., et al.
Publicado: (2019)

1125 Viral Infections In Outpatients With Medically Attended Acute Respiratory Illness During the 2012-13 Influenza Season
por: Zimmerman, Richard K., et al.
Publicado: (2014)

Vaccine effectiveness against COVID‐19 among symptomatic persons aged ≥12 years with reported contact with COVID‐19 cases, February–September 2021
por: Chung, Jessie R., et al.
Publicado: (2022)

1789. Comparison of influenza vaccine effectiveness estimates from the US Influenza Vaccine Effectiveness Network and Electronic Health Record Source Population Data, 2021-2022
por: McLean, Callie, et al.
Publicado: (2023)

1078 Risk Factors Associated with Developing Fever Following First Dose Measles-Containing Vaccines
por: Klein, Nicola P., et al.
Publicado: (2014)

1124 Clinical characteristics of adult patients with influenza B and A infections during 2013/2014 flu season
por: Ahn, Mi Young, et al.
Publicado: (2014)

Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2
por: Chung, Jessie R, et al.
Publicado: (2020)

Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014–2015
por: Petrie, Joshua G., et al.
Publicado: (2015)

784 Acute respiratory infections and Streptococcus pneumoniae Carriage
por: De Lastours, Victoire, et al.
Publicado: (2014)

1716 Engagement in OutSmart Flu, a smartphone-based surveillance system for influenza-like illness among students on a university campus
por: Sethi, Ajay K., et al.
Publicado: (2014)

1067 Multi-Attribute Ranking Tool for Vaccines: Strategic Priority Setting to Support Vaccine Development
por: Madhavan, Guruprasad, et al.
Publicado: (2014)

1080 Antibody Persistence 5 Years After Vaccination at 2 to 10 Years of Age With Quadrivalent MenACWY-CRM Conjugate Vaccine, And Responses To a Booster Vaccination
por: Block, Stanley L., et al.
Publicado: (2014)

530 Disease Modulation in Older Adults Vaccinated with High-Dose Versus Standard-Dose Influenza Vaccine
por: Talbot, H. Keipp, et al.
Publicado: (2014)

1050 Evaluation of syncope and related events following vaccination with quadrivalent human papillomavirus vaccine (2006-2013)
por: Lievano, Fabio, et al.
Publicado: (2014)

1063 Estimating Health Outcomes of Antiviral Use in Influenza (flu) Outbreaks by Linking PK/PD and Epidemiology via Transmission Dynamic Model: A Novel Approach
por: Smith, Patrick, et al.
Publicado: (2014)

Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study
por: Jackson, Michael L., et al.
Publicado: (2021)

Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020
por: Dawood, Fatimah S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6pckthk5luvb9gk8btbdnb2tvg